Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Monday, September 29

8:30 AM - 8:40 AM PT

186 - Characterizing Radiation Target Volumes and Patterns of Failure in Pediatric Neuroendocrine Tumors Using <sup>68</sup>Ga DOTA-Octreotate PET/CT
Speaker: McKone, Elizabeth, MD - Mayo Clinic Rochester, Rochester, MN
8:30 AM - 8:40 AM PT

191 - Preclinical Evaluation of First-in-Class PROTAC Survivin Degrader HMAK101 for Radiosensitization for GBM, DIPG and Brain Metastases
Speaker: Zheng, Shuhua, DO, PhD - Northwestern Feinberg School of Medicine, Chicago, IL
8:40 AM - 8:50 AM PT

181 - Validation of a Digital Twin-Based Clinical Trial Design Approach Combining Radiotherapy and Tyrosine Kinase Inhibitors: Prospective Virtual Trial Predictions Match Real-World Data
Speaker: McClatchy, David, PhD - Massachusetts General Hospital, Boston, MA
8:40 AM - 8:50 AM PT

187 - A Phase IV Surveillance Trial of Pencil Beam Scanning Proton Therapy in Children
Speaker: Lucas, John, MD, MS - St. Jude Children's Research Hospital, Memphis, TN
8:40 AM - 8:50 AM PT

192 - A Novel Therapeutic Approach Using ENO1-specific CAR-NK Cells to Target KRAS-Mutated Cancers
Speaker: Chao, K.S. Clifford, MD - China Medical University, Taiwan, Taichung, Taichung
8:50 AM - 9:00 AM PT

182 - Predictive Modeling Radiation-Induced Visual Field Deficits for Early Toxicity Detection
Speaker: Thariat, Juliette, MD, PhD - Centre François Baclesse, Caen, Normandy
8:50 AM - 9:00 AM PT

Discussant
Speaker: Casey, Dana, MD - University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC
8:50 AM - 9:00 AM PT

Discussant
Speaker: Young, Kristina, MD, PhD - Earle A. Chiles Research Institute, Portland, OR
10:45 AM - 10:55 AM PT

193 - Quality of life results from NRG-GU005: A Phase III Trial of SBRT vs. Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Speaker: Yu, James, MD, FASTRO, MHS - Dartmouth Hitchcock Medical Center, Lebanon, NH
10:45 AM - 10:55 AM PT

199 - Improved Progression-Free and Overall Survival with Radiotherapy Consolidation Post-Autologous Stem Cell Transplant in Patients with Relapsed/Refractory Aggressive Lymphoma with Pre-Transplant Partial Metabolic Response on FDG-PET
Speaker: Abeyakoon, Chathuri, MBBS - Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON
10:45 AM - 10:55 AM PT

204 - Contralateral Esophageal-Sparing Technique Reduces High-Grade Esophagitis in Locally Advanced Small Cell Lung Cancer: Updated Results from a Randomized Trial
Speaker: Xu, Yaping, PhD - Shanghai Pulmonary Hospital, Shanghai, Shanghai
10:45 AM - 10:55 AM PT

211 - Treatment with Stereotactic Ablative Radiotherapy for up to Five Oligometastases in Patients with Cancer: Long-Term Outcomes of the Nonrandomized Phase 2 SABR-5 Clinical Trial
Speaker: Leclerc, Curtis, MS - University of British Columbia, Vancouver, BC